Methylxanthine effects on cyclic adenosine 3':5' monophosphate phosphodiesterase activity in preparations of neonatal rat cerebellum: modification by trifluoperazine.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology*; D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D002110:Caffeine / Q000494:pharmacology*; D002531:Cerebellum / Q000187:drug effects / Q000201:enzymology*; D004347:Drug Interactions; D066298:In Vitro Techniques; D007700:Kinetics; D051381:Rats; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology*
D014268:Trifluoperazine; D002110:Caffeine; D013806:Theophylline; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015056:1-Methyl-3-isobutylxanthine